1. Home
  2. COMP vs CAI Comparison

COMP vs CAI Comparison

Compare COMP & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Inc.

COMP

Compass Inc.

HOLD

Current Price

$9.23

Market Cap

7.0B

Sector

Technology

ML Signal

HOLD

Logo Caris Life Sciences Inc.

CAI

Caris Life Sciences Inc.

N/A

Current Price

$28.32

Market Cap

6.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COMP
CAI
Founded
2012
2008
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
6.2B
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
COMP
CAI
Price
$9.23
$28.32
Analyst Decision
Buy
Buy
Analyst Count
12
14
Target Price
$15.17
★ $28.15
AVG Volume (30 Days)
★ 14.7M
4.2M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
67.74
★ 69.79
EPS
★ 0.14
N/A
Revenue
★ $6,961,600,000.00
$812,033,000.00
Revenue This Year
$106.95
$26.73
Revenue Next Year
$7.56
$18.03
P/E Ratio
$66.18
★ N/A
Revenue Growth
23.67
★ 96.97
52 Week Low
$6.37
$14.19
52 Week High
$13.96
$33.65

Technical Indicators

Market Signals
Indicator
COMP
CAI
Relative Strength Index (RSI) 37.57 50.54
Support Level $8.99 $16.52
Resistance Level $9.59 $28.82
Average True Range (ATR) 0.44 1.78
MACD -0.01 -0.44
Stochastic Oscillator 30.68 10.16

Price Performance

Historical Comparison
COMP
CAI

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

About CAI Caris Life Sciences Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: